Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Mark

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2009
Suppression of experimental autoimmune encephalomyelitis by ghrelinMichael-Mark Theil, Sachiko Miyake, Miho Mizuno, et al.
Investigational New Drugs|September 1, 2019
A Phase 1 study of BAL101553, a novel tumor checkpoint controller targeting microtubules, administered as 48-h infusion in adult patients with advanced solid tumorsMarkus Joerger, Anastasios Stathis, Yannis Metaxas, et al.
Cell Metabolism|July 30, 2020
SGLT2 Inhibition Mediates Protection from Diabetic Kidney Disease by Promoting Ketone Body-Induced mTORC1 InhibitionIssei Tomita, Shinji Kume, Sho Sugahara, et al.
BMC Cancer|February 20, 2021
Quality of life and pain in patients with metastatic bone disease from solid tumors treated with bone-targeted agents- a real-world cross-sectional study from Switzerland (SAKK 95/16)Karin Ribi, Beat Thürlimann, Corinne Schär, et al.
The Journal of Biological Chemistry|November 6, 2014
Hes3 is expressed in the adult pancreatic islet and regulates gene expression, cell growth, and insulin releaseJimmy Masjkur, Carina Arps-Forker, Steven W Poser, et al.
Journal of Bone Oncology|January 24, 2020
Patterns of care for patients with metastatic bone disease in solid tumors: A cross-sectional study from Switzerland (SAKK 95/16)Michael Mark, Beat Thürlimann, Karin Ribi, et al.
Lung Cancer (Amsterdam, Netherlands)|September 13, 2022
Fibroblast growth factor receptor (FGFR) inhibitor rogaratinib in patients with advanced pretreated squamous-cell non-small cell lung cancer over-expressing FGFR mRNA: The SAKK 19/18 phase II studyAlfredo Addeo, Sacha I Rothschild, Lisa Holer, et al.
Molecular Metabolism|April 20, 2021
Challenges in tackling energy expenditure as obesity therapy: From preclinical models to clinical applicationMona C Löffler, Matthias J Betz, Denis P Blondin, et al.
The Prostate|July 27, 2016
Orteronel Switch Maintenance Therapy in Metastatic Castration Resistant Prostate Cancer After First-Line Docetaxel: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial (SAKK 08/11)Richard Cathomas, Simon J Crabb, Michael Mark, et al.
International Journal of Radiation Oncology, Biology, Physics|March 7, 2020
Impact of Early Prophylactic Cranial Irradiation With Hippocampal Avoidance on Neurocognitive Function in Patients With Limited Disease Small Cell Lung Cancer. A Multicenter Phase 2 Trial (SAKK 15/12)Hansjörg Vees, Francesca Caparrotti, Eric Innocents Eboulet, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2009
Suppression of experimental autoimmune encephalomyelitis by ghrelinMichael-Mark Theil, Sachiko Miyake, Miho Mizuno, et al.
Investigational New Drugs|September 1, 2019
A Phase 1 study of BAL101553, a novel tumor checkpoint controller targeting microtubules, administered as 48-h infusion in adult patients with advanced solid tumorsMarkus Joerger, Anastasios Stathis, Yannis Metaxas, et al.
Cell Metabolism|July 30, 2020
SGLT2 Inhibition Mediates Protection from Diabetic Kidney Disease by Promoting Ketone Body-Induced mTORC1 InhibitionIssei Tomita, Shinji Kume, Sho Sugahara, et al.
BMC Cancer|February 20, 2021
Quality of life and pain in patients with metastatic bone disease from solid tumors treated with bone-targeted agents- a real-world cross-sectional study from Switzerland (SAKK 95/16)Karin Ribi, Beat Thürlimann, Corinne Schär, et al.
The Journal of Biological Chemistry|November 6, 2014
Hes3 is expressed in the adult pancreatic islet and regulates gene expression, cell growth, and insulin releaseJimmy Masjkur, Carina Arps-Forker, Steven W Poser, et al.
Journal of Bone Oncology|January 24, 2020
Patterns of care for patients with metastatic bone disease in solid tumors: A cross-sectional study from Switzerland (SAKK 95/16)Michael Mark, Beat Thürlimann, Karin Ribi, et al.
Lung Cancer (Amsterdam, Netherlands)|September 13, 2022
Fibroblast growth factor receptor (FGFR) inhibitor rogaratinib in patients with advanced pretreated squamous-cell non-small cell lung cancer over-expressing FGFR mRNA: The SAKK 19/18 phase II studyAlfredo Addeo, Sacha I Rothschild, Lisa Holer, et al.
Molecular Metabolism|April 20, 2021
Challenges in tackling energy expenditure as obesity therapy: From preclinical models to clinical applicationMona C Löffler, Matthias J Betz, Denis P Blondin, et al.
The Prostate|July 27, 2016
Orteronel Switch Maintenance Therapy in Metastatic Castration Resistant Prostate Cancer After First-Line Docetaxel: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial (SAKK 08/11)Richard Cathomas, Simon J Crabb, Michael Mark, et al.
International Journal of Radiation Oncology, Biology, Physics|March 7, 2020
Impact of Early Prophylactic Cranial Irradiation With Hippocampal Avoidance on Neurocognitive Function in Patients With Limited Disease Small Cell Lung Cancer. A Multicenter Phase 2 Trial (SAKK 15/12)Hansjörg Vees, Francesca Caparrotti, Eric Innocents Eboulet, et al.
Pageof 9